Ferring Pharmaceuticals to Present New Data Highlighting Future Assisted Reproductive Technology Market Trends at ASRM 2022 Scientific Congress & Expo - Yahoo Finance

2 years ago 89
  • Findings from the investigation underscore Ferring's committedness to identifying and addressing the needs of healthcare professionals and fertility session unit who are helping aspiring parents physique their families

, /PRNewswire/ -- Ferring Pharmaceuticals contiguous announced that it volition presenting a company-sponsored abstract highlighting an in-depth investigation of aboriginal trends successful the Assisted Reproductive Technology (ART) marketplace and volition besides big a merchandise theatre astatine the American Society for Reproductive Medicine (ASRM) 2022 Scientific Congress & Expo taking spot October 22-26 successful Anaheim, CA.

(PRNewsfoto/Ferring Pharmaceuticals)

(PRNewsfoto/Ferring Pharmaceuticals)

"We are pleased to stock caller information and perspectives astatine ASRM to lend to the robust legislature programme that volition proceed to beforehand the tract of reproductive medicine," said Elizabeth Garner, M.D., MPH, Chief Scientific Officer, Ferring Pharmaceuticals U.S. "Ferring's ongoing committedness to technological speech and successful supporting caller standards of attraction for aspiring parents is simply a apical precedence for the company."

Ferring's information presumption leveraged nationalist summaries of U.S. gonadotropin utilization arsenic compared to information provided by the Centers for Disease Control (CDC), to supply a forecast of aboriginal trends successful the ART market. This probe provides absorbing insights astir anticipated aboriginal attraction request and helps to guarantee availability of resources for radical gathering their families.

"After the contiguous effects of the COVID-19 planetary pandemic with astir 90% of clinics shutting down and diligent reluctance to question care, we person seen a important uptick and a pent-up request for fertility treatment, and it is captious that we amended recognize the imaginable marketplace dynamics truthful we tin beryllium prepared to enactment aspiring parents looking to physique their families," said Fady Sharara, M.D., FACOG, Virginia Center for Reproductive Medicine, and pb writer of the abstract. "I person personally seen the maturation successful gonadotropin utilization wrong my ain practice, and it's important information similar we're presenting astatine ASRM that volition supply the imaginable marketplace trends that healthcare providers and unit request to beryllium prepared successful their ain clinics."

In summation to the information presentation, Ferring volition big a merchandise theatre league titled, "Natural Cycle Frozen Embryo Transfer (FET) – is that the caller program?" led by Dr. Valerie Baker, Johns Hopkins University School of Medicine and Dr. Denis Vaughan, Boston IVF. There is an expanding inclination towards the show of earthy rhythm FETs implicit the existent modular of programmed FETs owed to the imaginable obstetric and objective benefits associated with earthy rhythm FETs. The merchandise theatre volition see a reappraisal of the lit comparing earthy rhythm FETs and programmed FETs, and a presumption reviewing outcomes from Boston IVF's earthy rhythm FET information and their acquisition with incorporating earthy rhythm FETs into their laboratory and objective workflow.

The details of Ferring's merchandise theatre league and abstract presumption are arsenic follows:

Ferring Product Theater Session
Title: Natural Cycle FET – is that the caller program?
Date and Time: Monday, October 24, 2022; 10:05am10:45am PDT

(PSW-08) E-Poster Abstract Station: W8
Title: Gonadotropin Utilization Data Can beryllium utilized arsenic an Indicator of U.S. Assisted Reproductive Technology (ART) Market Dynamics
Date and Time: Wednesday, October 26, 2022; 6:45am7:45am PDT

For much accusation connected Ferring's abstract presentation, sojourn asrmcongress.org/

About Ferring Pharmaceuticals

Ferring Pharmaceuticals is simply a research-driven, specialty biopharmaceutical radical committed to helping radical astir the satellite physique families and unrecorded amended lives. In the United States, Ferring is simply a person successful reproductive medicine and maternal health, and successful specialty areas wrong gastroenterology and orthopaedics. Ferring has been processing treatments for mothers and babies for implicit 50 years and has a portfolio covering treatments from conception to birth. Founded successful 1950, privately owned Ferring present employs astir 6,000 radical worldwide, has its ain operating subsidiaries successful astir 60 countries, and markets its products successful 110 countries.

Learn much at www.ferring.com, oregon link with america connected TwitterFacebookInstagramLinkedIn and YouTube.

For much information, delight contact

Lisa Perdomo
Director, Brand Communications
Ferring Pharmaceuticals
862-341-9820
Lisa.Perdomo@ferring.com

Cision

Cision

View archetypal contented to download multimedia:https://www.prnewswire.com/news-releases/ferring-pharmaceuticals-to-present-new-data-highlighting-future-assisted-reproductive-technology-market-trends-at-asrm-2022-scientific-congress--expo-301652659.html

SOURCE Ferring Pharmaceuticals

Read Entire Article